Society for Cardiovascular Angiography & Interventions SHOCK 2024

SCAI SHOCK: Home of the Shock Team

October 17–19, 2024 | Washington, D.C.

Explore a multidisciplinary approach to the contemporary management of cardiogenic shock with Society for Cardiovascular Angiography & Interventions SHOCK 2024 – SCAI SHOCK: Home of the Shock Team.

Held October 17–19, 2024, in Washington, D.C., this comprehensive meeting focuses on the clinical and organizational building blocks required to manage cardiogenic shock and develop effective institutional shock programs.

The conference provides a step-by-step approach to shock management, beginning with early recognition by EMS and emergency department teams and continuing through Shock ICU management, cath lab decision-making, mechanical circulatory support, multidisciplinary team coordination, quality improvement, post-danger care, and high-risk PCI.

Led by seasoned leaders, the program addresses both clinical management and systems-level considerations involved in delivering cardiogenic shock care across community and academic hospitals, urban and rural settings, and surgical and non-surgical environments.

Course Details

• Course: SCAI SHOCK: Home of the Shock Team
• Organization: Society for Cardiovascular Angiography & Interventions – SCAI
• Year: 2024
• Conference Dates: October 17–19, 2024
• Location: Washington, D.C.
• Primary Specialty: Interventional Cardiology
• Related Specialties: Critical Care, Heart Failure, Cardiothoracic Surgery
• Primary Clinical Focus: Contemporary Cardiogenic Shock Management
• Program Focus: Building and Optimizing Cardiogenic Shock Programs
• Primary Audience: Interventional Cardiologists, Intensivists, Cardiothoracic Surgeons, and Advanced Practice Providers
• Clinical Settings: Community and Academic Hospitals, Urban and Rural Locations, Surgical and Non-Surgical Settings

Who Was the Original Program Designed For?

The program brings together multidisciplinary professionals involved in cardiogenic shock care, including:

• Medical Intensivists
• Cardiac Intensivists
• Interventional Cardiologists
• Heart Failure Cardiologists
• Critical Care Cardiologists
• Cardiac Surgeons
• Advanced Practice Providers (APPs)
• Nurses
• Hospital Administrators
• Cardiovascular Service Line Leaders

It is particularly suitable for representatives of hospitals looking to improve, optimize, or formalize a cardiogenic shock program.

The program reflects the diversity of real-world cardiovascular practice, including:

• Community hospitals
• Academic hospitals
• Urban clinical settings
• Rural clinical settings
• Surgical environments
• Non-surgical environments
• Patients with advanced heart failure
• Patients without advanced heart failure

The strongest target audience includes Interventional Cardiologists, Intensivists, Cardiothoracic Surgeons, and Advanced Practice Providers (APPs) working in critical care.

Learning Objectives

The meeting will equip attendees with a comprehensive understanding of shock management, enabling them to:

• Integrate scientific updates and the latest evidence-based best practices for treating cardiogenic shock and cardiac arrest into clinical care.
• Implement optimal shock management strategies by utilizing EMS, transportation, and ED for early recognition and nuanced patient care.
• Apply Shock ICU essentials, including hemodynamic monitoring, vasoactive medications, and determining the appropriate ICU setting (dedicated vs. mixed).
• Optimize antiplatelet therapy and pharmacodynamic strategies for high-risk shock patients.
• Navigate complexities in the cath lab, such as understanding right heart hemodynamics, identifying unseen threats, and executing effective communication.
• Optimize team setup, tracking quality improvement (QI) metrics, and bridging communication gaps between shock clinicians and hospital administrators (C-suite).
• Execute problem-solving in the Cardiac ICU, including interpreting cardiac indices, troubleshooting MCS devices, and formulating weaning strategies.
• Manage post-danger care, evaluating the harms and benefits of inotropes, the role of IABP in community settings, and transitioning care for HF-shock patients.
• Manage resource allocation and coordination for High-risk PCI.
• Anticipate future directions, including the integration of novel support devices, machine learning for risk stratification, and AI in decision-making.

Contemporary Cardiogenic Shock Management

The central focus of SCAI SHOCK 2024 is the contemporary management of cardiogenic shock across multiple stages of care.

Rather than focusing on a single procedure or clinical environment, the program follows the shock patient across the care pathway:

Early Recognition → Transportation & ED → Shock ICU → Cath Lab → Team-Based Management → Cardiac ICU → Post-Danger Care

This multidisciplinary approach is intended to help clinicians and institutions understand how individual components of shock care interact within a coordinated program.

Early Recognition of Cardiogenic Shock

Early identification represents an important component of the shock management pathway addressed during the conference.

The program considers the roles of:

• EMS
• Patient transportation
• Emergency departments
• Early clinical recognition
• Initial patient assessment
• Coordination between care environments

The meeting emphasizes integrating these components into a more organized shock-management strategy.

EMS, Transportation & Emergency Department Care

The conference addresses the use of EMS, transportation systems, and emergency departments for early recognition and nuanced patient care.

These stages represent the beginning of the institutional shock pathway and can influence how patients transition toward specialized cardiovascular and critical care management.

Shock ICU Essentials

The program reviews essential considerations for managing patients in the Shock ICU.

Key areas include:

• Hemodynamic monitoring
• Vasoactive medications
• ICU organization
• Dedicated Shock ICU settings
• Mixed ICU settings

The conference also considers how institutions can determine the ICU model that fits their clinical environment.

Hemodynamic Monitoring

Hemodynamic assessment represents an important component of cardiogenic shock management.

The curriculum includes practical consideration of monitoring strategies and the interpretation of cardiovascular physiology in critically ill shock patients.

Vasoactive Medications

The Shock ICU portion of the program includes the use of vasoactive medications as part of contemporary cardiogenic shock care.

These treatment decisions are addressed within the wider context of hemodynamic management and individualized critical care.

Antiplatelet Therapy

The meeting addresses the optimization of antiplatelet therapy for patients with high-risk shock.

The program also considers pharmacodynamic strategies that may influence therapeutic decision-making in this complex population.

Cath Lab Complexities

The cardiac catheterization laboratory represents another major component of the SCAI SHOCK pathway.

The conference explores challenges including:

• Right heart hemodynamics
• Identification of unseen threats
• Complex cath lab decision-making
• Effective communication
• Coordination among shock clinicians

The emphasis extends beyond procedures to the clinical and communication challenges that can arise during complex shock cases.

Right Heart Hemodynamics

Understanding right heart hemodynamics is included among the key cath lab considerations addressed during the program.

The topic fits within the broader goal of improving physiologic assessment and decision-making in patients with cardiogenic shock.

Shock Team Development

A central concept of SCAI SHOCK: Home of the Shock Team is the development of an effective multidisciplinary shock team.

The program considers:

• Team setup
• Clinical coordination
• Communication
• Quality improvement
• Institutional organization
• Administrative collaboration

The objective is to translate shock-management principles into practical institutional systems.

Quality Improvement in Shock Programs

Institutions seeking to establish or improve a shock program require mechanisms for evaluating performance.

The conference addresses quality improvement (QI) metrics as part of building and optimizing cardiogenic shock systems of care.

Clinician & C-Suite Communication

The successful operation of a shock program may require collaboration beyond the bedside clinical team.

The program specifically addresses communication gaps between:

• Shock clinicians
• Hospital administrators
• C-suite leadership

This systems-level perspective supports hospitals seeking to formalize multidisciplinary shock programs.

Cardiac ICU Problem-Solving

The conference includes practical problem-solving within the Cardiac ICU.

Areas addressed include:

• Interpretation of cardiac indices
• Troubleshooting MCS devices
• Clinical decision-making
• Formulating weaning strategies

These topics focus on the challenges that arise after critically ill cardiovascular patients enter advanced intensive care management.

Mechanical Circulatory Support

MCS devices are an important component of advanced shock management covered within the program.

The curriculum addresses practical issues such as:

• Device troubleshooting
• Patient assessment
• Cardiac indices
• Weaning strategies

The program also considers future developments involving novel support devices.

Weaning Strategies

Determining how to transition patients from advanced circulatory support is included among the Cardiac ICU challenges discussed during the conference.

The program connects weaning decisions with ongoing hemodynamic evaluation and broader critical care management.

Post-Danger Care

The SCAI SHOCK pathway continues beyond the immediate danger phase of cardiogenic shock.

The meeting addresses post-danger care, including:

• Harms and benefits of inotropes
• Role of IABP in community settings
• Transitioning care
• Management of HF-shock patients

This emphasizes the importance of continued clinical planning after initial stabilization and advanced shock management.

Inotropes

The conference evaluates both the potential harms and benefits of inotropes in the management of shock patients.

The topic is considered within post-danger care and the transition toward longer-term cardiovascular management.

IABP in Community Settings

The role of IABP in community settings is specifically included in the program.

This reflects the conference’s goal of translating ideal shock-management strategies into the realities of different hospital environments.

Heart Failure & Shock

The curriculum addresses the transition of care for HF-shock patients.

This is particularly relevant to multidisciplinary teams involving:

• Heart Failure Cardiologists
• Intensivists
• Interventional Cardiologists
• Cardiothoracic Surgeons
• Advanced Practice Providers

The program recognizes that shock care may differ between patients with and without advanced heart failure.

High-Risk PCI

The conference addresses resource allocation and coordination for High-risk PCI.

This topic connects interventional cardiology with critical care resources, institutional planning, and multidisciplinary cardiovascular support.

Future Directions in Cardiogenic Shock

SCAI SHOCK 2024 also considers emerging approaches that may influence future cardiogenic shock management.

Topics include:

• Novel support devices
• Machine learning
• Risk stratification
• Artificial intelligence
• AI-assisted decision-making

These areas are presented within the context of future developments in cardiovascular shock care.

Machine Learning & Risk Stratification

The program explores the potential integration of machine learning for risk stratification.

This represents one of the emerging technological areas being considered in contemporary cardiogenic shock management.

Artificial Intelligence in Shock Care

Artificial intelligence is included among the future-focused areas of the conference.

The curriculum considers the integration of AI in clinical decision-making as shock management continues to evolve.

Building a Cardiogenic Shock Program

One of the defining features of SCAI SHOCK 2024 is its focus on helping institutions build and optimize shock programs.

Important components addressed across the meeting include:

• Early recognition
• EMS integration
• Transportation
• Emergency department management
• Shock ICU organization
• Hemodynamic monitoring
• Pharmacologic management
• Cath lab care
• Shock team coordination
• Quality improvement
• Administrative communication
• Cardiac ICU management
• MCS troubleshooting
• Weaning strategies
• Post-danger care
• High-risk PCI resource coordination
• Future technologies

The overall institutional pathway can be summarized as:

Recognize → Stabilize → Evaluate → Coordinate → Support → Reassess → Transition

Major Topics Covered

• Cardiogenic Shock
• Cardiac Arrest
• Shock Team
• SCAI SHOCK
• Interventional Cardiology
• Critical Care Cardiology
• Cardiovascular Critical Care
• Heart Failure
• Cardiothoracic Surgery
• EMS
• Emergency Department
• Patient Transportation
• Early Shock Recognition
• Shock ICU
• Cardiac ICU
• Hemodynamic Monitoring
• Right Heart Hemodynamics
• Vasoactive Medications
• Antiplatelet Therapy
• Pharmacodynamic Strategies
• Cath Lab Management
• Mechanical Circulatory Support
• MCS Devices
• Cardiac Indices
• MCS Troubleshooting
• Weaning Strategies
• Quality Improvement
• QI Metrics
• Shock Program Development
• Hospital Administration
• C-Suite Communication
• Inotropes
• IABP
• HF-Shock
• High-risk PCI
• Resource Allocation
• Novel Support Devices
• Machine Learning
• Risk Stratification
• Artificial Intelligence
• AI in Clinical Decision-Making
• Multidisciplinary Cardiogenic Shock Care

Who Should Take This Course?

The course is particularly relevant for:

• Interventional Cardiologists
• Medical Intensivists
• Cardiac Intensivists
• Critical Care Cardiologists
• Heart Failure Cardiologists
• Cardiothoracic Surgeons
• Advanced Practice Providers (APPs)
• Critical Care Nurses
• Cardiovascular Nurses
• Hospital Administrators
• Cardiovascular Service Line Leaders
• Members of multidisciplinary shock teams
• Representatives of hospitals establishing a shock program
• Representatives of hospitals optimizing an existing shock program

The strongest clinical audience remains:

Interventional Cardiology + Critical Care + Cardiothoracic Surgery + Heart Failure

Why This Course Is Useful

Society for Cardiovascular Angiography & Interventions SHOCK 2024 offers a multidisciplinary framework for understanding both the clinical and institutional aspects of contemporary cardiogenic shock management.

The program connects several critical stages of shock care:

Early Recognition & Initial Care

• EMS
• Transportation
• Emergency department
• Early identification of shock

Shock ICU Management

• Hemodynamic monitoring
• Vasoactive medications
• ICU configuration

Interventional & Cath Lab Care

• Right heart hemodynamics
• Antiplatelet therapy
• Cath lab complexities
• High-risk PCI

Advanced Critical Care

• Cardiac indices
• MCS troubleshooting
• Weaning strategies

Shock Program Infrastructure

• Team organization
• QI metrics
• Clinician communication
• C-suite collaboration

Post-Danger Care

• Inotropes
• IABP
• HF-shock transitions

Future Directions

• Novel support devices
• Machine learning
• Risk stratification
• Artificial intelligence

The program’s multidisciplinary approach makes it particularly relevant for institutions seeking to connect clinical decision-making, critical care, interventional cardiology, surgical expertise, administrative leadership, and quality improvement within a coordinated cardiogenic shock program.

Product Summary

• Product: Society for Cardiovascular Angiography & Interventions SHOCK 2024
• Meeting: SCAI SHOCK: Home of the Shock Team
• Organization: Society for Cardiovascular Angiography & Interventions – SCAI
• Year: 2024
• Conference Dates: October 17–19, 2024
• Location: Washington, D.C.
• Primary Specialty: Interventional Cardiology
• Related Specialties: Critical Care, Heart Failure, Cardiothoracic Surgery
• Primary Clinical Focus: Cardiogenic Shock
• Program Focus: Building and Optimizing Cardiogenic Shock Programs
• Primary Audience: Interventional Cardiologists, Intensivists, Cardiothoracic Surgeons, and Advanced Practice Providers
• Additional Audience: Nurses, Heart Failure Cardiologists, Critical Care Cardiologists, Hospital Administrators, and CV Service Line Leadership

Short Description

Society for Cardiovascular Angiography & Interventions SHOCK 2024 – SCAI SHOCK: Home of the Shock Team is a multidisciplinary conference focused on contemporary cardiogenic shock management and the development of effective institutional shock programs.

Held October 17–19, 2024, in Washington, D.C., the program covers early shock recognition, EMS and ED management, Shock ICU care, hemodynamic monitoring, vasoactive medications, antiplatelet therapy, right heart hemodynamics, cath lab complexities, MCS troubleshooting, weaning strategies, quality improvement, post-danger care, HF-shock, high-risk PCI, machine learning, and AI in clinical decision-making.

Topics

The program explores the major building blocks of contemporary cardiogenic shock management, including:

• Scientific Updates and Evidence-Based Cardiogenic Shock Care: Integration of current scientific updates and evidence-based best practices for cardiogenic shock and cardiac arrest.
• EMS, Transportation, and ED: Early recognition and nuanced patient management across prehospital transportation and emergency care.
• Shock ICU Essentials: Hemodynamic monitoring, vasoactive medications, and determining the appropriate ICU environment, including dedicated versus mixed settings.
• Antiplatelet Therapy and Pharmacodynamic Strategies: Optimization of treatment strategies for high-risk shock patients.
• Cath Lab Complexities: Right heart hemodynamics, unseen threats, complex clinical situations, and effective communication.
• Shock Team Setup and Quality Improvement: Team organization, QI metrics, and communication between clinicians and hospital administrators.
• Cardiac ICU Problem-Solving: Interpretation of cardiac indices, troubleshooting MCS devices, and development of weaning strategies.
• Post-Danger Care: Harms and benefits of inotropes, the role of IABP in community settings, and transitions of care for HF-shock patients.
• High-risk PCI: Resource allocation and multidisciplinary coordination.
• Future Directions: Novel support devices, machine learning for risk stratification, and artificial intelligence in clinical decision-making.

• Scientific Updates in Cardiogenic Shock and Cardiac Arrest: An Experiment With an N=1 Moving From Anecdote to Evidence (Future Trials and Therapeutic Concepts, ECLS Shock, DanGer Shock).

• The Shock ICU Never Miss a Beat: Vasoactive Medications in Cardiogenic Shock; Debate: Dedicated Cardiac ICU vs. Mixed ICU for Cardiogenic Shock Patients; Hemodynamic Monitoring; Palliative Care.

• Optimizing Antiplatelet Therapy in Cardiogenic Shock: Pharmacodynamics of Antiplatelet Therapies in CS; Optimal Antiplatelet Strategies in High-Risk Patients; Introductory Remarks & Cases (Part 1, Part 2); Cangrelor in AMI & CS.

• Contemporary Management of PE Patients in Shock: ECMO and Other MCS Devices in PE; Normotensive Shock; AClytics/CB/Thrombectomy When to Do What; Who Are We Enrolling in PE Trials; The Role of Surgery in PE.

• ECMO Workshop: What You Need to Know (Introduction, Equipment Review, Current Indications for ECMO); ECPR and ECMO (What’s New in ECMO, What’s After ECMO, Current State of ECPR, Considerations of VV ECMO).

• CICU Shock Problem-Solving: Weaning MCS Devices in the CICU; Troubleshooting MCS Devices in the CICU; Thermodilution Principles of CI Measurement Case Presentation; Fick Principles of CI Measurement Case Presentation.

• Cardiogenic Shock in the Cath Lab: Right Heart Hemodynamics Are They Really Necessary; MCS Escalation Identifying the Unseen Threat; Houston, We Have a Problem How Can I Voice Concerns and Make Suggestions; Case Studies and Debrief.

• Wellness: Protecting Our Team; It Was Just Too Much!; Balancing the Workload.

• Shock Complications: Keep Calm and Carry On Effective Use of ECPR for STEMI in an Agitated Patient; A Tale of Two Mitral Clips Mitral-TEER in Late Presenting STEMI with Acute Mitral Regurgitation and Cardiogenic Shock.

• Combat Shock: ECMO use in Advanced Heart Failure; ECMO Hub & Spoke – Houston!.

• The Role of EMS, Transport, and ED in the Management of Shock: The Challenges and Nuances of Transporting Patients on MCS; The ABCs of OHCA; How Level I, II, and III Shock Centers Should Work; Early Recognition of CS in EM and EMS; Difference in Profiles and Outcomes of In-House vs. Transfer Shock Patients.

• Complex PCI – Everything is Complex in Shock!: Your Tool Box How to Make Complex PCI Simpler; Introduction Remarks & CE Information; Importance of Intravascular Imaging in Complex PCI; Case When to Use Two Stents in Coronary Bifurcation; Case Using CTO Techniques in Complex PCI; Case How to Make a Complex PCI Simpler.

• Shock Coordinators in the ICUs: Beyond the Initial Call Tracking QI Metrics and Implementing Longitudinal Care; How to Set Up a Shock Team and Program Who’s on Your Team and How Do You Start; Shock Activation Process How to Sound the Alarm and What to Do Next; Role of Shock Coordinator Tips and Tricks to Optimize the Role.

• Future Directions in Shock – Charting a Path Forward: Novel Support Devices and Novel Ways to Use the Ones We Already Have; Integration of EMR for Early Recognition of CS; How Artificial Intelligence Can Inform Our Decision-Making in Cardiogenic Shock; From the ER to the ICU to the OR Invasive and Noninvasive Tools for Hemodynamic Monitoring.

• CS Care post-DanGer Shock: Not Just AMI-Shock, but HF-Shock Too; IABP An Important Tool in the Community; Harms and Benefit of Inotropes First; A Close Look at the IABP-Shock Trial.

• Cardiogenic Shock in Women: Vascular Access Considerations in Women; SCAI/FAPCI Women in CS Consensus Document; Right Ventricular Failure in Women; Diagnosis, Recognition, and Disparities.

• Bridging the Gap Between Shock Clinicians and the C-Suite: Case Presentation Dealing With CS Mortality & the Aftermath; Case Presentation Complexities in CS Coordination!.

• Top Shock Cases: Spontaneous Coronary Artery Dissection A Rare Cause of an Acute Myocardial Infarction; Cardiogenic Shock from Fulminant Constrictive Pericarditis due to Campylobacter jejuni; Clipping Shock MitraClip’s Rescue from Flecainide Toxicity and Severe Mitral Regurgitation-Induced Cardiogenic Shock; Venous-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) as a Bridge to Recovery in the Treatment of Amniotic Fluid Embolism (AFE)-Induced Cardiac Arrest.

• How and Why We Started Our Shock Programs (Invite Only): Welcome & Objectives; Challenges to Shock Care in Rural America; INOVA’s Journey in Shock An Example of a Community Hospital Accepting the Challenge.

• The Finances of a Starting a Shock Team (Invite Only): How to Ask for Support (Insider Knowledge to Get the Support Your Program Needs); The Financial Benefits of a Shock Program.

• Group Case Reviews (Invite Only): Case Review Table Assignments; Case 1, 2, 3, and 4.

• SoCCC Cardiogenic Shock Team Collaborative Think Tank (Invite Only)